Krista Hardy
Plastic and Reconstructive Surgery · Oak Park, ILNPI 1649624305
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.0%), travel and lodging and other — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Axogen at 43.1% of the total. Reporting peaked in 2024 at $2,285 and has fallen 77.9% since, to $505 in 2025.
Across 27 payments — averaging $121.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$1K
- Integra Lifesciences Corporation$1K
- RTI Surgical, Inc$274
- Davol Inc.$171
- BD$162
- Musculoskeletal Transplant Foundation Inc.$96
- plus $107 from 2 others
What the payments were for
- Travel & lodging$1,09033%
- Food & beverage$1,54647%
- Other$65220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 5 | $1,418 |
| Integra Lifesciences Corporation | 10 | $1,062 |
| RTI Surgical, Inc | 3 | $274 |
| Davol Inc. | 3 | $171 |
| BD | 2 | $162 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $96 |
| Bard Peripheral Vascular, Inc. | 1 | $83 |
| AbbVie | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$1,418
- AxoGuard Nerve Connector$1,418
- AxoGuard Nerve Protector$1,418
- AXOGUARD HA+ NERVE PROTECTOR$1,418
- AxoGuard Nerve Cap$1,418
- INTEGRA$674
- DuraSorb Monofilament Mesh$652
- INTEGRA DERMAL REGENERATION TEMPLATE$225
- PRIMATRIX$225
- CORTIVA ALLOGRAFT DERMIS$158
- Agento I.C. Silver-Coated Endotracheal Tube$146
How this compares
$3,288 in reported general payments places this provider in the 60th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $1,921 |
| Gabapentin | 32 | $205 |
| Oxycodone Hcl | 11 | $48 |
| Tramadol Hcl | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Oak Park
- John KimChicago$7.3M
- Mark SiscoNorthbrook$309K
- Steven SigaloveGlen Ellyn$218K
- Matthew EndaraJoliet$204K
- Brian MaileySpringfield$182K
- Julius FewChicago$148K
- Eleanor BucholzMaywood$63K
- Gregory DumanianChicago$50K
- Daniel LiuZion$47K
- Laurie CasasGlenview$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.